单剂联合纳米疫苗诱导快速持久的抗炭疽芽孢杆菌体液免疫和毒素中和抗体应答
本研究评估环二鸟苷酸(CDG)、聚酐纳米颗粒及其联合作为佐剂对炭疽保护性抗原(PA)诱导中和抗体的贡献。结果显示联合纳米疫苗单剂免疫后迅速产生高滴度中和性IgG抗PA抗体,并至少维持至免疫后108天。
要点
- 联合纳米疫苗单剂免疫可快速诱导高滴度抗PA中和抗体。
- 该抗体应答至少持续至免疫后108天(108 DPI)。
- CDG与聚酐纳米颗粒联合使用增强体液免疫应答。
核心结论
- 联合纳米疫苗单剂免疫可诱导快速、高滴度且持续至少108天的中和性IgG抗PA抗体应答。
研究设计与样本
- 评估CDG、聚酐纳米颗粒及其联合对炭疽保护性抗原(PA)诱导中和抗体的贡献。
主要发现
- 联合纳米疫苗单剂免疫后迅速产生高滴度中和性IgG抗PA抗体。
- 该抗体应答至少持续至免疫后108天(108 DPI)。
临床怎么用
- 联合纳米疫苗平台可能为炭疽暴露后预防提供更实用、有效的单剂疫苗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bacillus anthracis, the causative agent of anthrax, continues to be a prominent biological warfare and bioterrorism threat. Vaccination is likely to remain the most effective and user-friendly public health measure to counter this threat in the foreseeable future. The commercially available AVA BioThrax vaccine has a number of shortcomings where improvement would lead to a more practical and effective vaccine for use in the case of an exposure event. Identification of more effective adjuvants and novel delivery platforms is necessary to improve not only the effectiveness of the anthrax vaccine, but also enhance its shelf stability and ease-of-use. Polyanhydride particles have proven to be an effective platform at adjuvanting the vaccine-associated adaptive immune response as well as enhancing stability of encapsulated antigens. Another class of adjuvants, the STING pathway-targeting cyclic dinucleotides, have proven to be uniquely effective at inducing a beneficial inflammatory response that leads to the rapid induction of high titer antibodies post-vaccination capable of providing protection against bacterial pathogens. In this work, we evaluate the individual contributions of cyclic di-GMP (CDG), polyanhydride nanoparticles, and a combination thereof towards inducing neutralizing antibody (nAb) against the secreted protective antigen (PA) from B. anthracis. Our results show that the combination nanovaccine elicited rapid, high titer, and neutralizing IgG anti-PA antibody following single dose immunization that persisted for at least 108 DPI.
引用
- Kelly SM, Larsen KR, Darling R, et al. Single-dose combination nanovaccine induces both rapid and durable humoral immunity and toxin neutralizing antibody responses against Bacillus anthracis. Vaccine. 2021. PMID: 34090702. doi:10.1016/j.vaccine.2021.05.077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。